Metoprolol Succinate
Product Images NDC 75834-292

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 75834-292). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

80e517c8-figure-01 (80e517c8 Figure 01)

Chemical structure of Metoprolol Succinate, depicting the molecular components including a benzene ring with hydroxyl and ether substitutions, as well as the succinate moiety with carboxyl groups.*

FDA Label Image

C:\users\amber.chen\pictures\mts-figure.jpg (80e517c8 Figure 02)

A forest plot illustrating subgroup analysis results from the MERIT-HE study, showing relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure comparing metoprolol succinate extended release tablets versus placebo across various patient subgroups such as geographical region, NYHA class, ejection fraction, medical history, and heart rate.*

FDA Label Image

3 (Mts100 1000ct)

Label for Metoprolol Succinate Extended-Release Tablets USP 100 mg from Nivagen Pharmaceuticals, Inc. The label shows the NDC 75834-292-00 and indicates a package size of 1000 tablets. It includes storage instructions, a warning to keep out of reach of children, and contact information for the manufacturer. The label also displays a barcode and the Nivagen logo.*

FDA Label Image

1 (Mts100 100ct)

The label is for Metoprolol Succinate Extended-Release Tablets USP, 100 mg strength, in a package containing 100 tablets. It highlights the NDC 75834-292-01 and shows the Nivagen Pharmaceuticals, Inc. logo. The label includes storage instructions, a warning to keep out of reach of children, and the manufacturer's contact information.*

FDA Label Image

2 (Mts100 500ct)

Label for Metoprolol Succinate Extended-Release Tablets USP, 100 mg strength, supplied in a package of 500 tablets. The label includes the NDC 75834-292-05, storage instructions at controlled room temperature, and a warning to keep out of reach of children. The product is manufactured for Nivagen Pharmaceuticals, Inc., Sacramento, CA.*

FDA Label Image

6 (Mts200 1000ct)

Label for Metoprolol Succinate Extended-Release Tablets USP, 200 mg strength, manufactured by Nivagen Pharmaceuticals, Inc. The label states the NDC 75834-293-00, indicates a package size of 1000 tablets, and includes storage instructions and a warning to keep out of children's reach. A barcode and company logo are also visible.*

FDA Label Image

4 (Mts200 100ct)

Label for Metoprolol Succinate Extended-Release Tablets USP 200 mg, manufactured by Nivagen Pharmaceuticals, Inc. The label indicates a package containing 100 tablets, with storage and dispensing instructions, a warning to keep out of reach of children, and a toll-free contact number. The NDC code is 75834-293-01.*

FDA Label Image

5 (Mts200 500ct)

Label for Metoprolol Succinate Extended-Release Tablets USP, 200 mg strength, manufactured by Nivagen Pharmaceuticals, Inc. The label states the product is prescription only and contains 500 tablets. It includes storage instructions, dosage note, and warnings, along with a barcode and NDC 75834-293-05.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.